Mobile App

Google Play Apple Store
What's New in PAH? Evidence from ATS, ERS, and CHEST 2023 for Improved Clinical Care
Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee.

Pulmonary arterial hypertension (PAH) is a severe condition with a high mortality rate despite advances in diagnostic and therapeutic strategies. In recent years, significant scientific progress has been made in the understanding of the underlying pathobiological mechanisms with novel therapeutic compounds in development. In this on-demand video presentation, our PAH experts will review practice-changing results presented at the 2023 ATS, ERS, and CHEST meetings to assess their potential future incorporation into clinical practice for patients with PAH.
Review the activity and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.

Mardi Gomberg-Maitland, MD, MSc Mardi Gomberg-Maitland, MD, MSc
Professor of Medicine
Chief, Clinical Research Officer
George Washington University  

Marius Hoeper, MD Marius Hoeper, MD
Professor, Department of Respiratory Medicine
Hannover Medical School

Supported by an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA

Launch Date: November 13, 2023
Release Date: October 30, 2023
Expiration Date: October 31, 2024

October 31, 2024
Mini Module


Change Settings